Trial intelligence / Profile preview

Topical Bimatoprost for Chemical Blepharoplasty

NCT02830776Phase 1Completed

Sponsor
Tulane University
Start
Nov 2016
Primary completion
Apr 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of bimatoprost in dermatochalasis, sponsored by Tulane University. Primary endpoint: Graded Change in Dermatochalasis at 12 weeks. Started Nov 2016; status: completed.

02

Drugs

bimatoprost
03

Conditions

dermatochalasis

Beyond the preview

Go deeper on NCT02830776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02830776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call